Jingxin Pharm's two subsidiaries to build VD3 projects

On 11–17 Feb., Shandong Jingxin Pharmaceutical Co., Ltd. (Shandong Jingxin)'s project of 24,702 t/a APIs and intermediates was publicised before environmental impact assessment (EIA) approval.Project overview:Total investment: USD321.95 million...

Vitamins China E-News 202202

www.cnchemicals.com